Lipoprotein(a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology
Open accessThe DOI matches its Crossref record; 290 of the 290 references it cites were found in a registry or an index.
Abstract
Scanu, and colleagues cloned and sequenced the LPA gene coding for apo(a) (4, 5), a protein with homology to plasminogen, which accounts for the difference between an Lp(a) particle and an LDL particle.These observations generated a huge scientific interest in Lp(a), leading to an exponential growth in the number of articles published, which then later declined again.Renewed interested in Lp(a) came in 2009 from Pia Kamstrup et al. ( 6) with genetic evidence from Mendelian randomization that high Lp(a) is causally associated with cardiovascular disease, from the Emerging Risk Factors Collaboration led by John Danesh that Lp(a) epidemiologically is continuously and independently associated with cardiovascular disease risk (7), and from Robert Clarke et al. (8) that of 2,100 candidate genes for cardiovascular disease, genetic variation in the LPA gene was the strongest genetic cardiovascular risk factor.Following the publication of these studies, high concentrations of Lp(a) have been considered to be a direct cause of cardiovascular disease, just like high LDL cholesterol concentrations.Genetic evidence largely free of confounding and fully free of reverse causation, two major problems of observational epidemiology, is what has cemented the understanding of causality of Lp(a) for cardiovascular disease.These novel and important findings led the European Atherosclerosis Society to publish a 2010 consensus panel statement recommending screening for elevated Lp(a) in individuals at intermediate, high, or very high cardiovascular risk, and suggested a desirable plasma concentration of less than 50 mg/dl (9).Of note, we naturally were fully aware that the risk of cardiovascular disease increases already at Lp(a) levels above 30 mg/dl, but to get the attention of the clinical community, we believed it was the best strategy to start focusing on individuals with the highest cardiovascular risk, that is, the 20% of individuals with concentrations above 50 mg/dl.Abstract Human epidemiologic and genetic evidence using the Mendelian randomization approach in large-scale studies now strongly supports that elevated lipoprotein (a) [Lp(a)] is a causal risk factor for cardiovascular disease, that is, for myocardial infarction, atherosclerotic stenosis, and aortic valve stenosis.The Mendelian randomization approach used to infer causality is generally not affected by confounding and reverse causation, the major problems of observational epidemiology.This approach is particularly valuable to study causality of Lp(a), as single genetic variants exist that explain 27-28% of all variation in plasma Lp(a).The most important genetic variant likely is the kringle IV type 2 (KIV-2) copy number variant, as the apo(a) product of this variant influences fibrinolysis and thereby thrombosis, as opposed to the Lp(a) particle per se.We speculate that the physiological role of KIV-2 in Lp(a) could be through wound healing during childbirth, infections, and injury, a role that, in addition, could lead to more blood clots promoting stenosis of arteries and the aortic valve, and myocardial infarction.Randomized placebo-controlled trials of Lp(a) reduction in individuals with very high concentrations to reduce cardiovascular disease are awaited.Recent genetic evidence documents elevated Lp(a) as a cause of myocardial infarction, atherosclerotic stenosis, and aortic valve stenosis.-Nordestgaard,B. G., and A. Langsted.Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Elevated baseline and on-statin treatment Lp(a) concentration above the 80th percentile of the general population (50 mg/dL) is a strong genetic risk factor for cardiovascular disease independent of LDLC [23,24].”
From Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM (2020) · cites this paper as [23]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Furthermore, several randomized trials have shown that directly infused HDL mimetics increase plasma HDL-C concentrations, but do not reduce the progression of atherosclerosis as measured by intravascular ultrasound [68,69].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [69]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
Davey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882
Mendelian randomization: genetic anchors for causal inference in epidemiological studies
Davey Smith, G., & Hemani, G. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu328 · Cited by 4,677
Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
Lawlor, D. A., Harbord, R. M., Sterne, J. A. C., Timpson, N., & Davey Smith, G. (2008) · Statistics in Medicine · doi:10.1002/sim.3034 · Cited by 4,618
PEDERSEN, T. R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.027 · Cited by 3,106
Nordestgaard, B. G., Chapman, M. J., Humphries, S. E., Ginsberg, H. N., Masana, L., Descamps, O. S., Wiklund, O., Hegele, R. A., Raal, F. J., Defesche, J. C., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht273 · Cited by 2,761
Self-citationClinical Factors Associated With Calcific Aortic Valve Disease
Stewart, B. F., Siscovick, D., Lind, B. K., Gardin, J. M., Gottdiener, J. S., Smith, V. E., Kitzman, D. W., & Otto, C. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00563-3 · Cited by 2,029
cDNA sequence of human apolipoprotein(a) is homologous to plasminogen
McLean, J. W., Tomlinson, J. E., Kuang, W.-J., Eaton, D. L., Chen, E. Y., Fless, G. M., Scanu, A. M., & Lawn, R. M. (1987) · Nature · doi:10.1038/330132a0 · Cited by 1,886 · cited 3×
“ogy with plasminogen (4, 39), Lp(a) may promote thrombosis by competing with plasminogen and thereby inhibiting the role of plasmin in dissolving fibrin clots (34, 255–257).”
BackgroundLarge-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
Cardiogenics, Schunkert, H., the CARDIoGRAM Consortium, König, I. R., Kathiresan, S., Reilly, M. P., Assimes, T. L., Holm, H., Preuss, M., Stewart, A. F. R., et al. (2011) · Nature Genetics · doi:10.1038/ng.784 · Cited by 1,866
Lipoprotein(a) as a cardiovascular risk factor: current status
Nordestgaard, B. G., Chapman, M. J., Ray, K., Borén, J., Andreotti, F., Watts, G. F., Ginsberg, H., Amarenco, P., Catapano, A., Descamps, O. S., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq386 · Cited by 1,807
Self-citation(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753
Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Clarke, R., Peden, J. F., Hopewell, J. C., Kyriakou, T., Goel, A., Heath, S. C., Parish, S., Barlera, S., Franzosi, M. G., Rust, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902604 · Cited by 1,671
Triglycerides and cardiovascular disease
Nordestgaard, B. G., & Varbo, A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61177-6 · Cited by 1,419
Self-citationA NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEM
Berg, K. (1963) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1963.tb01808.x · Cited by 1,372
Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
Kamstrup, P. R. (2009) · JAMA · doi:10.1001/jama.2009.801 · Cited by 1,357 · cited 10×
“5% of the time in the Danish registries and the follow-up in this population is 100% complete (6).”
BackgroundMethodInfluentialThe mysteries of lipoprotein(a).
Utermann, G. (1989) · Science · doi:10.1126/science.2530631 · Cited by 1,257
Mendelian randomization: prospects, potentials, and limitations
Smith, G. D. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh132 · Cited by 1,222
Nordestgaard, B. G. (2016) · Circulation Research · doi:10.1161/circresaha.115.306249 · Cited by 1,116
Self-citationCuchel, M., Bruckert, E., Ginsberg, H. N., Raal, F. J., Santos, R. D., Hegele, R. A., Kuivenhoven, J. A., Nordestgaard, B. G., Descamps, O. S., Steinhagen-Thiessen, E., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu274 · Cited by 1,057
Self-citationGenetic Associations with Valvular Calcification and Aortic Stenosis
Thanassoulis, G., Campbell, C. Y., Owens, D. S., Smith, J. G., Smith, A. V., Peloso, G. M., Kerr, K. F., Pechlivanis, S., Budoff, M. J., Harris, T. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109034 · Cited by 1,008
Self-citationSharrett, A. R., Ballantyne, C. M., Coady, S. A., Heiss, G., Sorlie, P. D., Catellier, D., & Patsch, W. (2001) · Circulation · doi:10.1161/hc3501.095214 · Cited by 944
Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies
Danesh, J., Collins, R., & Peto, R. (2000) · Circulation · doi:10.1161/01.cir.102.10.1082 · Cited by 938
Dahlen, G. H., Guyton, J. R., Attar, M., Farmer, J. A., Kautz, J. A., & Gotto, A. M. (1986) · Circulation · doi:10.1161/01.cir.74.4.758 · Cited by 911
Wiegman, A., Gidding, S. S., Watts, G. F., Chapman, M. J., Ginsberg, H. N., Cuchel, M., Ose, L., Averna, M., Boileau, C., Borén, J., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv157 · Cited by 891
Self-citationUtermann, G., Menzel, H. J., Kraft, H. G., Duba, H. C., Kemmler, H. G., & Seitz, C. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113093 · Cited by 881
Clarke, R., Shipley, M., Lewington, S., Youngman, L., Collins, R., Marmot, M., & Peto, R. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010013 · Cited by 877
Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease
Tsimikas, S., Brilakis, E. S., Miller, E. R., McConnell, J. P., Lennon, R. J., Kornman, K. S., Witztum, J. L., & Berger, P. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043175 · Cited by 784
Lp(a) Lipoprotein as a Risk Factor for Myocardial Infarction
Rhoads, G. G. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03380180102027 · Cited by 783
Stary, H. C., Chandler, A. B., Glagov, S., Guyton, J. R., Insull, W., Rosenfeld, M. E., Schaffer, S. A., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.5.840 · Cited by 742
Tsai, A. W., Cushman, M., Rosamond, W. D., Heckbert, S. R., Polak, J. F., & Folsom, A. R. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.10.1182 · Cited by 700
Varbo, A., Benn, M., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2013) · Circulation · doi:10.1161/circulationaha.113.003008 · Cited by 692
Self-citationLipoprotein Lp(a) and the risk for myocardial infarction
Kostner, G. M., Avogaro, P., Cazzolato, G., Marth, E., Bittolo-Bon, G., & Qunici, G. B. (1981) · Atherosclerosis · doi:10.1016/0021-9150(81)90103-9 · Cited by 687
van der Valk, F. M., Bekkering, S., Kroon, J., Yeang, C., Van den Bossche, J., van Buul, J. D., Ravandi, A., Nederveen, A. J., Verberne, H. J., Scipione, C., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.020838 · Cited by 674
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction
Do, R., Stitziel, N. O., Won, H.-H., Jørgensen, A. B., Duga, S., Angelica Merlini, P., Kiezun, A., Farrall, M., Goel, A., Zuk, O., et al. (2015) · Nature · doi:10.1038/nature13917 · Cited by 650
Structure, function, and genetics of lipoprotein (a)
Schmidt, K., Noureen, A., Kronenberg, F., & Utermann, G. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r067314 · Cited by 638
Benn, M., Watts, G. F., Tybjaerg-Hansen, A., & Nordestgaard, B. G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1563 · Cited by 632
Self-citationArmstrong, V. W., Cremer, P., Eberle, E., Manke, A., Schulze, F., Wieland, H., Kreuzer, H., & Seidel, D. (1986) · Atherosclerosis · doi:10.1016/0021-9150(86)90099-7 · Cited by 626
Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population
Kamstrup, P. R., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.038 · Cited by 595
Self-citationSeed, M., Hoppichler, F., Reaveley, D., McCarthy, S., Thompson, G. R., Boerwinkle, E., & Utermann, G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005243222104 · Cited by 585
Lipoprotein (a). Heterogeneity and biological relevance.
Scanu, A. M., & Fless, G. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114625 · Cited by 573
O’Brien, K. D., Reichenbach, D. D., Marcovina, S. M., Kuusisto, J., Alpers, C. E., & Otto, C. M. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.4.523 · Cited by 560
Kamstrup, P. R., Benn, M., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2008) · Circulation · doi:10.1161/circulationaha.107.715698 · Cited by 558
Self-citationRosengren, A., Wilhelmsen, L., Eriksson, E., Risberg, B., & Wedel, H. (1990) · BMJ · doi:10.1136/bmj.301.6763.1248 · Cited by 539
Alfthan, G., Pekkanen, J., Jauhiainen, M., Pitkäniemi, J., Karvonen, M., Tuomilehto, J., Salonen, J. T., & Ehnholm, C. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90078-7 · Cited by 527
Lipoprotein(a): resurrected by genetics
Kronenberg, F., & Utermann, G. (2013) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02592.x · Cited by 521
Hallman, D. M., Boerwinkle, E., Saha, N., Sandholzer, C., Menzel, H., Csazar, A., & Utermann, G. (1991) · PubMed · Cited by 513
A Prospective Study of Lipoprotein(a) and the Risk of Myocardial Infarction
Ridker, P. M. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510180065035 · Cited by 512
Wellcome Trust Case Control Consortium, Trégouët, D.-A., Cardiogenics Consortium, König, I. R., Erdmann, J., Munteanu, A., Braund, P. S., Hall, A. S., Großhennig, A., Linsel-Nitschke, P., et al. (2009) · Nature Genetics · doi:10.1038/ng.314 · Cited by 475
Lipoprotein(a), fibrin binding, and plasminogen activation.
Loscalzo, J., Weinfeld, M., Fless, G. M., & Scanu, A. M. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.2.240 · Cited by 461
Angio-immunoblastic lymphadenopathy with dysproteinemia
Frizzera, G. (1974) · The Lancet · Cited by 461
Assmann, G., Schulte, H., & von Eckardstein, A. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00159-2 · Cited by 447
Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients.
Rath, M., Niendorf, A., Reblin, T., Dietel, M., Krebber, H. J., & Beisiegel, U. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.5.579 · Cited by 446
Sjouke, B., Kusters, D. M., Kindt, I., Besseling, J., Defesche, J. C., Sijbrands, E. J. G., Roeters van Lennep, J. E., Stalenhoef, A. F. H., Wiegman, A., de Graaf, J., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu058 · Cited by 443
Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis
Capoulade, R., Chan, K. L., Yeang, C., Mathieu, P., Bossé, Y., Dumesnil, J. G., Tam, J. W., Teo, K. K., Mahmut, A., Yang, X., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.020 · Cited by 417
Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age
Sandkamp, M., Funke, H., Schulte, H., Köhler, E., & Assmann, G. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.1.20 · Cited by 417
Benn, M., Watts, G. F., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw028 · Cited by 400
Self-citationBostom, A. G. (1996) · JAMA · doi:10.1001/jama.1996.03540070040028 · Cited by 398
Sandholzer, C., Hallman, D. M., Saha, N., Sigurdsson, G., Lackner, C., Cs�sz�r, A., Boerwinkle, E., & Utermann, G. (1991) · Human Genetics · doi:10.1007/bf00201550 · Cited by 386
APOUPOPROTEIN E ISOFORMS, SERUM CHOLESTEROL, AND CANCER
Katan, M. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92972-7 · Cited by 371
Marcovina, S. M., Albers, J. J., Gabel, B., Koschinsky, M. L., & Gaur, V. P. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.2.246 · Cited by 354
Jauhiainen, M., Koskinen, P., Ehnholm, C., Frick, M. H., Mänttäri, M., Manninen, V., & Huttunen, J. K. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90007-p · Cited by 354
Apo(a) isoforms predict risk for coronary heart disease. A study in six populations.
Sandholzer, C., Saha, N., Kark, J. D., Rees, A., Jaross, W., Dieplinger, H., Hoppichler, F., Boerwinkle, E., & Utermann, G. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.10.1214 · Cited by 352
Apolipoprotein(a) Isoforms and the Risk of Vascular Disease
Erqou, S., Thompson, A., Di Angelantonio, E., Saleheen, D., Kaptoge, S., Marcovina, S., & Danesh, J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.080 · Cited by 332
Lipoprotein(a) as a strong indicator for cerebrovascular disease.
Zenker, G., Költringer, P., Boné, G., Niederkorn, K., Pfeiffer, K., & Jürgens, G. (1986) · Stroke · doi:10.1161/01.str.17.5.942 · Cited by 329
Palmer, T. M., Sterne, J. A. C., Harbord, R. M., Lawlor, D. A., Sheehan, N. A., Meng, S., Granell, R., Smith, G. D., & Didelez, V. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr026 · Cited by 325
Virani, S. S., Brautbar, A., Davis, B. C., Nambi, V., Hoogeveen, R. C., Sharrett, A. R., Coresh, J., Mosley, T. H., Morrisett, J. D., Catellier, D. J., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.045120 · Cited by 324
Lp(a) lipoprotein and pre‐β1‐lipoprotein in patients with coronary heart disease
Berg, K., Dahlén, G., & Frick, M. H. (1974) · Clinical Genetics · doi:10.1111/j.1399-0004.1974.tb00657.x · Cited by 316
Arsenault, B. J., Boekholdt, S. M., Dubé, M.-P., Rhéaume, É., Wareham, N. J., Khaw, K.-T., Sandhu, M. S., & Tardif, J.-C. (2014) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.113.000400 · Cited by 315
Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
Boffa, M. B., & Koschinsky, M. L. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r060582 · Cited by 309
Jansen, A. C. M., van Aalst‐Cohen, E. S., Tanck, M. W., Trip, M. D., Lansberg, P. J., Liem, A. H., Roeters van Lennep, H. W. O., Sijbrands, E. J. G., & Kastelein, J. J. P. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01405.x · Cited by 302
Genetic epidemiology and public health: hope, hype, and future prospects
Smith, G. D., Ebrahim, S., Lewis, S., Hansell, A. L., Palmer, L. J., & Burton, P. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67601-5 · Cited by 300
CREMER, P., NAGEL, D., LABROT, B., MANN, H., MUCHE, R., ELSTER, H., & SEIDEL, D. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb02373.x · Cited by 298
Lp(a) Lipoprotein, Vascular Disease, and Mortality in the Elderly
Ariyo, A. A., Thach, C., & Tracy, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa001066 · Cited by 288
Marcovina, S. M., Koschinsky, M. L., Albers, J. J., & Skarlatos, S. (2003) · Clinical Chemistry · doi:10.1373/clinchem.2003.023689 · Cited by 288
APOLIPOPROTEINS (a), AI, AND B AND PARENTAL HISTORY IN MEN WITH EARLY ONSET ISCHAEMIC HEART DISEASE
Durrington, P. N., Hunt, L., Ishola, M., Arrol, S., & Bhatnagar, D. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91895-8 · Cited by 283
Fless, G. M., ZumMallen, M. E., & Scanu, A. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84439-3 · Cited by 274
Afzal, S., Brondum-Jacobsen, P., Bojesen, S. E., & Nordestgaard, B. G. (2014) · BMJ · doi:10.1136/bmj.g6330 · Cited by 270
Self-citationLangsted, A., Kamstrup, P. R., Benn, M., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30042-0 · Cited by 270
Self-citationBoerwinkle, E., Menzel, H. J., Kraft, H. G., & Utermann, G. (1989) · Human Genetics · doi:10.1007/bf00288277 · Cited by 262
Lipoprotein (a): impact by ethnicity and environmental and medical conditions
Enkhmaa, B., Anuurad, E., & Berglund, L. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r051904 · Cited by 260
Bostom, A. G., Gagnon, D. R., Cupples, L. A., Wilson, P. W., Jenner, J. L., Ordovas, J. M., Schaefer, E. J., & Castelli, W. P. (1994) · Circulation · doi:10.1161/01.cir.90.4.1688 · Cited by 255
Cushing, G. L., Gaubatz, J. W., Nava, M. L., Burdick, B. J., Bocan, T. M., Guyton, J. R., Weilbaecher, D., DeBakey, M. E., Lawrie, G. M., & Morrisett, J. D. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.5.593 · Cited by 252
Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors
Nowak-Gottl, U. (2001) · Blood · doi:10.1182/blood.v97.4.858 · Cited by 250
Hoff, H. F., Beck, G. J., Skibinski, C. I., Jürgens, G., O'Neil, J., Kramer, J., & Lytle, B. (1988) · Circulation · doi:10.1161/01.cir.77.6.1238 · Cited by 249
Lipoprotein(a) and Risk of Type 2 Diabetes
Mora, S., Kamstrup, P. R., Rifai, N., Nordestgaard, B. G., Buring, J. E., & Ridker, P. M. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.146779 · Cited by 242
Self-citationApolipoproteins and ischaemic heart disease: implications for screening
Wald, N., Watt, H., Bailey, A., Johnson, M., Ledue, T. B., & Haddow, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90814-1 · Cited by 241
Teaching old dogmas new tricks
Brown, M. S., & Goldstein, J. L. (1987) · Nature · doi:10.1038/330113a0 · Cited by 238
Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans
Marcovina, S. M., Albers, J. J., Wijsman, E., Zhang, Z., Chapman, N. H., & Kennedy, H. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37461-7 · Cited by 237
Rader, D. J., Cain, W., Ikewaki, K., Talley, G., Zech, L. A., Usher, D., & Brewer, H. B. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117292 · Cited by 236
VIRUS-INFECTION OF URINARY-TRACT
Brouwers, T. M., Fontein, D. L., & Value, N. (1974) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 236
Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases
Kronenberg, F. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6648-3 · Cited by 230
Caplice, N. M., Panetta, C., Peterson, T. E., Kleppe, L. S., Mueske, C. S., Kostner, G. M., Broze, G. J., & Simari, R. D. (2001) · Blood · doi:10.1182/blood.v98.10.2980 · Cited by 228
Lipoprotein (a) : structure, properties and possible involvement in thrombogenesis and atherogenesis
Mbewu, A. D., & Durrington, P. N. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90177-k · Cited by 228
Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study
Luc, G., Bard, J.-M., Arveiler, D., Ferrieres, J., Evans, A., Amouyel, P., Fruchart, J.-C., & Ducimetiere, P. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00026-6 · Cited by 227
Increased Lipoprotein(a) Is an Important Risk Factor for Venous Thromboembolism in Childhood
Nowak-Göttl, U., Junker, R., Hartmeier, M., Koch, H.-G., Münchow, N., Assmann, G., & von Eckardstein, A. (1999) · Circulation · doi:10.1161/01.cir.100.7.743 · Cited by 225
Lp(a) lipoprotein in cardiovascular disease
Dahlén, G. H. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90106-6 · Cited by 219
Suk Danik, J., Rifai, N., Buring, J. E., & Ridker, P. M. (2006) · JAMA · doi:10.1001/jama.296.11.1363 · Cited by 216
Rader, D. J., Hoeg, J. M., & Brewer, H. B. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-12-199406150-00008 · Cited by 216
Mendelian randomization studies in coronary artery disease
Jansen, H., Samani, N. J., & Schunkert, H. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu208 · Cited by 212
Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies
Craig, W. Y., Neveux, L. M., Palomaki, G. E., Cleveland, M. M., & Haddow, J. E. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.11.2301 · Cited by 210
Utermann, G., Duba, C., & Menzel, H. J. (1988) · Human Genetics · doi:10.1007/bf00291233 · Cited by 206
Lipoprotein (a) as a risk factor for ischemic stroke: A meta-analysis
Nave, A. H., Lange, K. S., Leonards, C. O., Siegerink, B., Doehner, W., Landmesser, U., Steinhagen-Thiessen, E., Endres, M., & Ebinger, M. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.08.021 · Cited by 200
Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia
Wiklund, O., Olofsson, S.-O., Fager, G., Bondjers, G., Angelin, B., Erikson, M., & Berglund, L. (1990) · The Lancet · doi:10.1016/0140-6736(90)91242-3 · Cited by 198
Nowak-Göttl, U., Wermes, C., Junker, R., Koch, H.-G., Schobess, R., Fleischhack, G., Schwabe, D., & Ehrenforth, S. (1999) · Blood · doi:10.1182/blood.v93.5.1595 · Cited by 198
Lipoprotein(a) as a strong indicator for cerebrovascular disease.
GZenker, PKöltringer, GBoné, et al. (1986) · Stroke · Cited by 197
Wild, S. H., Fortmann, S. P., & Marcovina, S. M. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.2.239 · Cited by 194
Kamstrup, P. R., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.248765 · Cited by 194
Self-citationvon Eckardstein, A., Schulte, H., Cullen, P., & Assmann, G. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01126-8 · Cited by 187
Helgadottir, A., Gretarsdottir, S., Thorleifsson, G., Holm, H., Patel, R. S., Gudnason, T., Jones, G. T., van Rij, A. M., Eapen, D. J., Baas, A. F., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.078 · Cited by 187
The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.
Rader, D. J., Mann, W. A., Cain, W., Kraft, H. G., Usher, D., Zech, L. A., Hoeg, J. M., Davignon, J., Lupien, P., & Grossman, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117794 · Cited by 176
Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism
von Depka, M., Nowak-Göttl, U., Eisert, R., Dieterich, C., Barthels, M., Scharrer, I., Ganser, A., & Ehrenforth, S. (2000) · Blood · doi:10.1182/blood.v96.10.3364 · Cited by 174
Paultre, F., Pearson, T. A., Weil, H. F. C., Tuck, C. H., Myerson, M., Rubin, J., Francis, C. K., Marx, H. F., Philbin, E. F., Reed, R. G., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.12.2619 · Cited by 174
Boffa, M. B., Marcovina, S. M., & Koschinsky, M. L. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2003.12.007 · Cited by 172
Lipoprotein(a) as a Determinant of Coronary Heart Disease in Young Women
Orth-Gome´r, K., Mittleman, M. A., Schenck-Gustafsson, K., Wamala, S. P., Eriksson, M., Belkic, K., Kirkeeide, R., Svane, B., & Ryde´n, L. (1997) · Circulation · doi:10.1161/01.cir.95.2.329 · Cited by 172
Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study
Thomsen, M., Varbo, A., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2013.219881 · Cited by 171
Self-citationTybjaerg-Hansen, A., Agerholm-Larsen, B., Humphries, S. E., Abildgaard, S., Schnohr, P., & Nordestgaard, B. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119499 · Cited by 167
Self-citationGotoh, T., Kuroda, T., Yamasawa, M., Nishinaga, M., Mitsuhashi, T., Seino, Y., Nagoh, N., Kayaba, K., Yamada, S., Matsuo, H., et al. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80263-x · Cited by 167
Sandholzer, C., Boerwinkle, E., Saha, N., Tong, M. C., & Utermann, G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115645 · Cited by 164
Bihari-Varga, M., Gruber, E., Rotheneder, M., Zechner, R., & Kostner, G. M. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.6.851 · Cited by 161
Surprises from genetic analyses of lipid risk factors for atherosclerosis
Musunuru, K., & Kathiresan, S. (2016) · Circulation Research · doi:10.1161/circresaha.115.306398 · Cited by 159
Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up
Kosch, A., Kuwertz-Bröking, E., Heller, C., et al. (2004) · Blood · doi:10.1182/blood-2004-01-0229 · Cited by 157
How to avoid bias when comparing bone marrow transplantation with chemotherapy.
Gray, R. G., & Wheatley, K. (1991) · PubMed · Cited by 156
Genetics of the quantitative Lp(a) lipoprotein trait
Utermann, G., Kraft, H. G., Menzel, H. J., Hopferwieser, T., & Seitz, C. (1988) · Human Genetics · doi:10.1007/bf00291232 · Cited by 155
Kamstrup, P. R., & Nordestgaard, B. G. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70064-0 · Cited by 153
Self-citationKraft, H. G., Lingenhel, A., Pang, R. W. C., Delport, R., Trommsdorff, M., Vermaak, H., Janus, E. D., & Utermann, G. (1996) · European Journal of Human Genetics · doi:10.1159/000472175 · Cited by 152
Cantin, B., Gagnon, F., Moorjani, S., Després, J., Lamarche, B., Lupien, P. J., & Dagenais, G. R. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00528-7 · Cited by 152
Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease
Revel‐Vilk, S., Chan, A. K. C., Bauman, M. E., et al. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00158.x · Cited by 151
Rouy, D., Grailhe, P., Nigon, F., Chapman, J., & Anglés‐Cano, E. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.3.629 · Cited by 148
Determinants of severity of coronary artery disease in Australian men and women.
Wang, X. L., Tam, C., McCredie, R. M., & Wilcken, D. E. L. (1994) · Circulation · doi:10.1161/01.cir.89.5.1974 · Cited by 141
Matthews, K. A., Sowers, M. F., Derby, C. A., Stein, E. A., Miracle-McMahill, H. L., Crawford, S. L., & Pasternak, R. C. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.08.027 · Cited by 140
Antisense inhibition of apolipoprotein (a) to lower plasma lipoprotein (a) levels in humans
Graham, M. J., Viney, N., Crooke, R. M., & Tsimikas, S. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r052258 · Cited by 139
Gaw, A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117263 · Cited by 137
Nguyen, T. T., Ellefson, R. D., Hodge, D. O., Bailey, K. R., Kottke, T. E., & Abu-Lebdeh, H. S. (1997) · Circulation · doi:10.1161/01.cir.96.5.1390 · Cited by 133
Nielsen, L. B. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00064-7 · Cited by 132
Lipoprotein[a] as a risk factor for preclinical atherosclerosis.
Schreiner, P. J., Morrisett, J. D., Sharrett, A. R., Patsch, W., Tyroler, H. A., Wu, K., & HEISS, G. M. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.6.826 · Cited by 132
Inhibition of Fibrinolysis by Lipoprotein(a)
Anglés‐Cano, E., de la Peña-Díaz, A., & Loyau, S. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03514.x · Cited by 131
Atherosclerosis and arterial influx of lipoproteins
Nordestgaard, B. G., & Nielsen, L. B. (1994) · Current Opinion in Lipidology · doi:10.1097/00041433-199408000-00002 · Cited by 128
Self-citationHeller, C., Schobeß, R., Kurnik, K., et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02349.x · Cited by 128
Heller, C., Schobeß, R., Kurnik, K., et al. (2000) · British Journal of Haematology · doi:10.1111/j.1365-2141.2000.02349.x · Cited by 127
Rifai, N., Ma, J., Sacks, F. M., Ridker, P. M., Hernandez, W. J. L., Stampfer, M. J., & Marcovina, S. M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.030031 · Cited by 127
Valentine, R. J., Grayburn, P. A., Vega, G. L., & Grundy, S. M. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420070129015 · Cited by 124
Lipoprotein(a) in Homozygous Familial Hypercholesterolemia
Kraft, H. G., Lingenhel, A., Raal, F. J., Hohenegger, M., & Utermann, G. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.2.522 · Cited by 121
Smith, E. B., Keen, G. A., & GRANT, A. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90087-y · Cited by 115
Vongpromek, R., Bos, S., ten Kate, G. R., Yahya, R., Verhoeven, A. J. M., de Feyter, P. J., Kronenberg, F., van Lennep, J. E. R., Sijbrands, E. J. G., & Mulder, M. T. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12335 · Cited by 115
Dahlén, G., Berg, K., Gillnäs, T., & Ericson, C. (1975) · Clinical Genetics · doi:10.1111/j.1399-0004.1975.tb00338.x · Cited by 113
Lipoprotein(a) and ischemic heart disease—A causal association? A review
Kamstrup, P. R. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.12.036 · Cited by 112
The Association Between Circulating Lipoprotein(a) and Type 2 Diabetes: Is It Causal?
Ye, Z., Haycock, P., Gurdasani, D., Pomilla, C., Boekholdt, S. M., Tsimikas, S., Khaw, K., Wareham, N. J., Sandhu, M. S., & Forouhi, N. G. (2013) · Diabetes · doi:10.2337/db13-1144 · Cited by 110
Kronenberg, F., Trenkwalder, E., Dieplinger, H., & Utermann, G. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.12.1568 · Cited by 106
Lipoprotein(a): more interesting than ever after 50 years
Dubé, J. B., Boffa, M. B., Hegele, R. A., & Koschinsky, M. L. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32835111d8 · Cited by 105
Lipoprotein(a), Cardiovascular Disease, and Contemporary Management
Jacobson, T. A. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.09.003 · Cited by 105
Marcucci, R., Liotta, A. A., Cellai, A. P., Rogolino, A. A., Gori, A. M., Giusti, B., Poli, D., Fedi, S., Abbate, R., & Prisco, D. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.06.005 · Cited by 103
Budde, T., Fechtrup, C., Bösenberg, E., Vielhauer, C., Enbergs, A., Schulte, H., Assmann, G., & Breithardt, G. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.11.1730 · Cited by 103
Helmhold, M., Bigge, J., Muche, R., Mainoo, J., Thiery, J., Seidel, D., & Armstrong, V. W. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41895-4 · Cited by 103
Smith, E. B., & Cochran, S. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90088-z · Cited by 103
Thanassoulis, G. (2015) · Journal of Lipid Research · doi:10.1194/jlr.r051870 · Cited by 101
Mbewu, A. D., Bhatnagar, D., Durrington, P. N., Hunt, L. P., Ishola, M., Arrol, S., Mackness, M., Lockley, P., & Miller, J. P. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.4.940 · Cited by 100
Ding, L., Song, A., Dai, M., Xu, M., Sun, W., Xu, B., Sun, J., Wang, T., Xu, Y., Lu, J., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.p049015 · Cited by 100
Mechanisms of Lipoprotein(a) Pathogenicity
Spence, J. D., & Koschinsky, M. L. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.251306 · Cited by 100
Lipoprotein (a) in Heart Disease
Lawn, R. M. (1992) · Scientific American · doi:10.1038/scientificamerican0692-54 · Cited by 98
Qi, Q., Workalemahu, T., Zhang, C., Hu, F. B., & Qi, L. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr350 · Cited by 98
Serum Lipids in Angiographically Assessed Coronary Atherosclerosis
Frick, M. H., Dahlén, G. H., Berg, K., et al. (1978) · CHEST Journal · doi:10.1378/chest.73.1.62 · Cited by 95
Niendorf, A., Rath, M., Wolf, K., et al. (1990) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf02190527 · Cited by 93
Ober, C., Nord, A. S., Thompson, E. E., Pan, L., Tan, Z., Cusanovich, D. A., Sun, Y., Nicolae, R. I., Edelstein, C., Schneider, D., et al. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800515-jlr200 · Cited by 93
Simon, D. I., Fless, G. M., Scanu, A. M., & Loscalzo, J. (1991) · Biochemistry · doi:10.1021/bi00241a006 · Cited by 93
Nsaibia, M. J., Mahmut, A., Boulanger, M., Arsenault, B. J., Bouchareb, R., Simard, S., Witztum, J. L., Clavel, M.-A. A., Pîbarot, P., Bossé, Y., et al. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12519 · Cited by 93
When should we measure lipoprotein (a)?
Kostner, K., März, W., & Kostner, G. M. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht053 · Cited by 92
Lipoprotein (a) and Venous Thromboembolism in Adults: A Meta-Analysis
Sofi, F., Marcucci, R., Abbate, R., Gensini, G. F., & Prisco, D. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.01.029 · Cited by 89
The genetics of the Lp Antigen: II. A family study and proposed models of genetic control
Sing, C. F., Schultz, J. S., & Shreffler, D. C. (1974) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1974.tb01992.x · Cited by 86
Atsumi, T., Khamashta, M. A., Andujar, C., et al. (1998) · PubMed · Cited by 85
Studies on an extra pre-beta lipoprotein fraction.
Dahlén, G., Ericson, C., Furberg, C. D., Lundkvist, L., & Svärdsudd, K. (1972) · PubMed · Cited by 85
Simons, L. A., Friedlander, Y., SIMONS, J., & McCallum, J. C. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90054-x · Cited by 84
Holmer, S. R., Hengstenberg, C., Kraft, H.-G., Mayer, B., Pöll, M., Kürzinger, S., Fischer, M., Löwel, H., Klein, G., Riegger, G. A. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000048125.79640.77 · Cited by 83
Glader, C. A. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00385-8 · Cited by 83
Cambillau, M., Simon, A. C., Amar, J., Giral, P., Atger, V., Segond, P., Levenson, J. A., Merli, I. P., Mégnien, J. L., & Plainfosse, M. C. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.11.1346 · Cited by 81
Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis
Undas, A., Stępień, E. Ł., Tracz, W., & Szczeklik, A. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01903.x · Cited by 81
Lipoprotein(a) Is Associated Differentially With Carotid Stenosis, Occlusion, and Total Plaque Area
Klein, J., Hegele, R. A., Hackam, D. G., Koschinsky, M. L., Huff, M. W., & Spence, J. D. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.169292 · Cited by 80
Apolipoprotein(a) isoforms and coronary heart disease in men
Klausen, I. C., Sjøl, A., HANSEN, P. S., Gerdes, L. U., Møller, L. F., Lemming, L., Schroll, M., & Færgeman, O. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00071-3 · Cited by 77
Proteomics of Lipoprotein(a) identifies a protein complement associated with response to wounding
von Zychlinski, A., Kleffmann, T., Williams, M. J. A., & McCormick, S. P. A. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.07.008 · Cited by 77
Brown, S. A., Morrisett, J. D., Boerwinkle, E., Hutchinson, R. G., & Patsch, W. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.11.1558 · Cited by 77
Soutar, A. K., McCarthy, S., Seed, M., et al. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115329 · Cited by 76
The vascular endothelial barrier — selective retention of lipoproteins
Nordestgaard, B. G. (1996) · Current Opinion in Lipidology · doi:10.1097/00041433-199610000-00002 · Cited by 74
Self-citationBaldassarre, D., Tremoli, E., Franceschini, G., Michelagnoli, S., & Sirtori, C. R. (1996) · Stroke · doi:10.1161/01.str.27.6.1044 · Cited by 73
Tate, J. R., Rifai, N., Berg, K., Couderc, R., Dati, F., Kostner, G. M., Sakurabayashi, I., & Steinmetz, A. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.8.1629 · Cited by 72
Mölgaard, J., Klausen, I. C., Lassvik, C., Færgeman, O., Gerdes, L. U., & OLSSON, A. G. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.8.895 · Cited by 71
A prospective study of obesity, lipids, apolipoproteins and ischaemic heart disease in women
Coleman, M. P., Key, T. J. A., Wang, D. Y., Hermon, C., Fentiman, I. S., Allen, D., Jarvis, M. J., Pike, M. C., & Sanders, T. A. B. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90276-m · Cited by 71
Specific Accumulation of Lipoprotein(a) in Balloon-Injured Rabbit Aorta In Vivo
Nielsen, L. B., Stender, S., Kjeldsen, K., & Nordestgaard, B. G. (1996) · Circulation Research · doi:10.1161/01.res.78.4.615 · Cited by 70
Self-citationVolpato, S., Vigna, G. B., McDermott, M. M., Cavalieri, M., Maraldi, C., Lauretani, F., Bandinelli, S., Zuliani, G., Guralnik, J. M., Fellin, R., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.01.370 · Cited by 69
Bottalico, L. A., Keesler, G. A., Fless, G. M., & Tabas, I. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52913-6 · Cited by 68
The genetics of quantitative plasma Lp(a): Analysis of a large pedigree
Hasstedt, S. J., Wilson, D. E., Edwards, C. Q., Cannon, W. N., Carmelli, D., Williams, R. R., & Opitz, J. M. (1983) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320160208 · Cited by 67
Lipoprotein (a): Its Role in Childhood Thromboembolism
Nowak‐Göttl, U., Debus, O., Findeisen, M., Kassenböhmer, R., Koch, H. G., Pollmann, H., Postler, C., Weber, P., & Vielhaber, H. (1997) · PEDIATRICS · doi:10.1542/peds.99.6.e11 · Cited by 66
Berg, K. A. R., & Mohr, J. (1963) · Human Heredity · doi:10.1159/000151818 · Cited by 65
Lipoprotein(a): novel target and emergence of novel therapies to lower cardiovascular disease risk
Tsimikas, S. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000237 · Cited by 65
Nordestgaard, B. G., & Tybjærg‐Hansen, A. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834477d2 · Cited by 64
Self-citationIn Vivo Transfer of Lipoprotein(a) Into Human Atherosclerotic Carotid Arterial Intima
Nielsen, L. B., Grønholdt, M.-L. M., Schroeder, T. V., Stender, S., & Nordestgaard, B. G. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.5.905 · Cited by 63
Self-citationMika Kivimaki, B., Magnussen, C. G., Juonala, M., Kähönen, M. A. P., Kettunen, J., Loo, B.-M., Lehtimäki, T. J., Viikari, J. S. A., & Raitakari, O. T. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyq205 · Cited by 62
Genetics of the Lp lipoprotein in Japanese‐Americans
Morton, N. E., Berg, K., Dahlén, G. H., Ferrell, R. E., Rhoads, G. G., & Rao, D. C. (1985) · Genetic Epidemiology · doi:10.1002/gepi.1370020202 · Cited by 61
Kyriakou, T., Seedorf, U., Goel, A., Hopewell, J. C., Clarke, R., Watkins, H. C., & Farrall, M. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303462 · Cited by 61
Cited by
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601
Self-citationKronenberg, F., Mora, S., Stroes, E. S. G., Ference, B. A., Arsenault, B. J., Berglund, L., Dweck, M. R., Koschinsky, M., Lambert, G., Mach, F., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac361 · Cited by 1,449
Self-citation
Metadata
- Authors
- Nordestgaard, B. G., & Langsted, A.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Nordestgaard, Børge G.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 57
- Issue
- 11
- Pages
- 1953-1975
- ISSN
- 0022-2275 (ISSN-L)
- PMC
- PMC5087876
- OpenAlex
- W2526556731
- Cited by
- 575
- References
- 290
- Citations by year
- 2026: 46 · 2025: 66 · 2024: 72 · 2023: 65 · 2022: 72 · 2021: 59 · 2020: 67 · 2019: 60 · 2018: 37 · 2017: 28 · 2016: 2
- FWCI
- 8.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 1410 d)
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- lipoprotein(a), cardiovascular disease, causal risk factors, LPA gene, Mendelian randomization, genetic association, plasminogen homology, aortic stenosis, myocardial infarction, atherosclerotic stenosis, Lp(a) screening, LDL cholesterol, reverse causality, confounding
- MeSH terms
- Aortic Valve Stenosis, Cardiovascular Diseases, Humans, Myocardial Infarction, Risk Factors, Lipoprotein(a), Genetic Predisposition to Disease, DNA Copy Number Variations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.